Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination
| Autor: | Leung, Victoria S, Lin, Yuankai |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
and promotion of well-being
Prevention Evaluation of treatments and therapeutic interventions Prevention of disease and conditions pancytopenia Vaccine Related rituximab Rare Diseases Good Health and Well Being COVID‐19 vaccine 3.4 Vaccines 6.1 Pharmaceuticals Immunization lympholysis COVID-19 vaccine |
| Zdroj: | Clinical case reports, vol 9, iss 8 |
| Popis: | Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have been reported for rituximab, and new guidelines regarding the timing of rituximab infusion and vaccination are urgently needed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|